Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Xalacom

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Abstract Purpose: We investigated the transcorneal penetration of commercial ophthalmic formulations containing timolol maleate… Expand
2015
2015
  • M. Fukuda, H. Sasaki
  • Journal of ocular pharmacology and therapeutics…
  • 2015
  • Corpus ID: 24277046
PURPOSE We investigated the transcorneal penetration of commercial ophthalmic formulations containing timolol maleate in rabbit… Expand
Review
2014
Review
2014
A new preservative-free fixed-dose combination of 0.0015% tafluprost, a prostaglandin F2α analog, and 0.5% timolol (TAF/TIM… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
2013
2013
IntroductionThe purpose of this case is to present the use of pattern electroretinogram (PERG) in the early diagnosis of normal… Expand
  • figure 1
  • figure 3
  • figure 4
  • figure 6
2011
2011
PurposeTo evaluate the safety of fixed-combination latanoprost/timolol (Xalacom) in patients requiring additional intraocular… Expand
2011
2011
The combination of anti-glaucoma eye drops is frequently used in clinical treatment, and it is known that the combination can… Expand
  • table 1
  • figure 2
  • figure 1
  • figure 3
  • figure 4
2008
2008
Once-daily administration of fixed-combination latanoprost and timolol in patients with open-angle glaucoma and ocular… Expand
  • figure 1
2005
2005
Objective:  To compare the costs of the new fixed combinations for glaucoma medical therapy. 
2005
2005
ABSTRACT Purpose: To evaluate the daily cost of antiglaucoma eyedropsand the economic impact related to the minimal wage; to com… Expand